Cargando...
Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta‐analysis
BACKGROUND: Long‐acting bronchodilators such as long‐acting β‐agonist (LABA), long‐acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations have been used in people with moderate to severe chronic obstructive pulmonary disease (COPD) to control symptoms such as dyspnoe...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2018
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517098/ https://ncbi.nlm.nih.gov/pubmed/30521694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012620.pub2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|